Akso Health (AHG) Long-Term Investments (2017 - 2025)

Akso Health has reported Long-Term Investments for 9 years, with the latest figure at $202.6 million in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Investments rose 43.24% year-over-year to $202.6 million; the trailing twelve-month figure through Mar 2025 stood at $202.6 million (up 43.24% YoY), and the FY2025 full-year result was $202.6 million, up 43.24% from the prior year.
• Long-Term Investments for Q1 2025 stood at $202.6 million, up from $141.5 million in the prior quarter.
• The five-year high for Long-Term Investments was $202.6 million in Q1 2025, with the low at $11.3 million in Q1 2023.
• Historically, Long-Term Investments has averaged $80.1 million across 5 years, with a median of $30.8 million in 2021.
• Annual changes were most pronounced in 2021 — Long-Term Investments soared 1824.61% — and 2022, when it sank 53.45%.
• Akso Health's Long-Term Investments stood at $30.8 million in 2021, then slumped by 53.45% to $14.3 million in 2022, then dropped by 21.14% to $11.3 million in 2023, then surged by 1151.38% to $141.5 million in 2024, then soared by 43.24% to $202.6 million in 2025.
• The last three Long-Term Investments figures came in at $202.6 million (Q1 2025), $141.5 million (Q1 2024), and $11.3 million (Q1 2023), per Business Quant data.